Lisinopril is unique among ACE inhibitors as it is not metabolized by the liver and is excreted unchanged in the urine. This characteristic means that liver function does not significantly impact its clearance from the body, but kidney function does. Patients with impaired renal function require dose adjustments to prevent accumulation and potential toxicity.
